Facilities that are subject to FSMA inspections are struggling with the initial implementation of the Foreign Supplier Verification Provision of the law, new data shows. The issue is coming to a head with the first warning letter based on a FSVP failure.
A study using cranberries supplied by Fruit d’Or outlines a new test method for quantifying the insoluble proanthocyanidins (PACs) within the fruit. The method could potentially open up new avenues of research for ingredients derived from the berry.
Indonesia’s first microalgae firm PT Evergen Resources is on a mission to meet the country’s astaxanthin demands across the nutra, pharma and cosmetics sectors.
A key element of the CBD debate will be determining best practices of when and how to measure the THC content of products, said an expert with long experience in the botanicals field.
Biotech firms are reaping the rewards of a project looking into foods tackling metabolic syndrome resulting in products like microalgae, omega-3 and antioxidant-infused juices and algae-derived omega 3 oil.
The Clorox Company is yet another CPG giant that has found a salve for sore earnings in the nutritional products sector. Recent investments in the dietary supplment category provided bright spots in an otherwise flaccid year end report.
Trade body Complementary Medicines Australia (CMA) has reassured the safety of Australian made supplements but cautioned against the online purchase of overseas products, amid ongoing doping saga involving national swimmer Shayna Jack.
Organic foods and dietary supplements retailer Natural Grocers has posted a solid earnings quarter as it takes a break from its prior mode of rapid growth in the number of stores.
Herbalife’s share price plunged after the company reported disappointing second quarter earnings and reduced its future outlook that foresees sales possibly falling for the full year results.
President Trump has announced new 10% tariffs on an additional $300 billion world of Chinese goods. The move unveiled yesterday means tariffs will now likely apply to most dietary supplements whose ingredients come from China, sparking questions of what...
Bod Australia has stated that the absence of a clear pathway to market for its CBD products explains why APAC is “not yet on the radar” for its recently announced distribution deal with NewH2.
